Loading...
OTCM
EVAHF
Market cap260kUSD
Oct 08, Last price  
0.02USD
1D
0.00%
1Q
-25.33%
IPO
-98.21%
Name

EGF Theramed Health Corp

Chart & performance

D1W1MN
OTCM:EVAHF chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
134.71%
Rev. gr., 5y
%
Revenues
0
Net income
-3m
L+1,014.19%
-3,034-3,034-340,000-54,463-278,000-195,000-36,936,000-936,000-14,395,000-20,228,000-974,000-1,350,000-623,000-269,253-3,000,000
CFO
30k
P
0-1-22,708-40,574-15,830-68,06013,376-454,620-2,039,251-1,707,026-783,761-993,417-576,012-13429,770

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to address various mental health challenges. The company's products are specifically utilized in the treatment of conditions such as intractable depression, anxiety disorders, post-traumatic stress disorder (PTSD), and general depression. Established in 2011, this firm operates from its main headquarters in Vancouver, Canada.
IPO date
Jun 20, 2013
Employees
Domiciled in
CA
Incorporated in
CA
Headquarters & legal address
SUITE 1600 - 609 GRANVILLE ST
VANCOUVER, BC V7Y 1C3
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT